Author

I. Darasingh

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

A. C. Christopher· 1 shared A. K. Dhyani· 1 shared A. Srivastava· 1 shared G. Mahalingam· 1 shared M. Moorthy· 1 shared M. Murugesan· 1 shared N. Devaraju· 1 shared P. Arjunan· 1 shared

Activity by Year

2022-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

A. C. Christopher

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Correlating the differences in the receptor binding domain of SARS-CoV-2 spike variants on their interactions with human ACE2 receptor

G. Mahalingam, P. Arjunan, Y. Periasami, A. K. Dhyani, N. Devaraju, V. Rajendiran, A. C. Christopher, R. D. KT, I. Darasingh, S. Thangavel, M. Murugesan, M. Moorthy, A. Srivastava, S. Marepally

The paper evaluates binding interactions of SARS-CoV-2 spike variants with hACE2 using ELISA and cellular models, finding that N501Y in RBD enhances binding efficiency, particularly distinguishing C.1.2 from Delta.

bioRxiv · Sep 30, 2022 · PreprintPharmacology & Toxicology